Literature DB >> 17102548

Antimalarial drug resistance and the importance of drug quality monitoring.

M D Green1.   

Abstract

The availability of counterfeit and poor quality drugs contribute to resistance and erroneous efficacy study results as well as directly affecting the health of individuals. This report describes the importance of drug quality monitoring as part of a comprehensive disease surveillance program.

Mesh：

Substances：

Year:  2006        PMID： 17102548

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


  5 in total

Review 1.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Quality of chloroquine tablets available in Africa.

Authors:  C W Sawadogo; M Amood Al-Kamarany; H M Al-Mekhlafi; M Elkarbane; A H Al-Adhroey; Y Cherrah; A Bouklouze
Journal:  Ann Trop Med Parasitol       Date:  2011-09

Review 3.  New medicines to improve control and contribute to the eradication of malaria.

Authors:  Timothy N C Wells; Pedro L Alonso; Winston E Gutteridge
Journal:  Nat Rev Drug Discov       Date:  2009-10-16       Impact factor: 84.694

4.  Substandard anti-malarial drugs in Burkina Faso.

Authors:  Maike Tipke; Salou Diallo; Boubacar Coulibaly; Dominic Störzinger; Torsten Hoppe-Tichy; Ali Sie; Olaf Müller
Journal:  Malar J       Date:  2008-05-27       Impact factor: 2.979

5.  Antimalarial drug quality in the most severely malarious parts of Africa - a six country study.

Authors:  Roger Bate; Philip Coticelli; Richard Tren; Amir Attaran
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.